Considering the prolonged half-life of most GLP-1 agonists currently prescribed, it is unfeasible to withhold these agents for weeks prior to surgery to achieve normalisation of gastric function with unknown impact on aspiration rates, appreciating the detrimental effects of poorer glycaemic control on withholding these agents and associated higher risk of peri/postoperative complications (major cardiovascular events, poor wound healing, increased wound infection etc.)
Metsera formally launched Thursday, about 2 years after its founding by Arch Venture Partners and Population Health Partners
The duration of BPC 157's benefits is highly individualized and often depends on the specific condition being addressed and your overall health
Annual review of nutrition 34, 237260, doi: 10.1146/annurev-nutr-071812-161201 (2014)
Taken together, the results of numerous small studies equivocally suggest that GLP-1 RA treatment in coronary artery disease patients would be beneficial, regardless of the presence of diabetes